Outcomes Differences of Seronegative and Seropositive Pediatric Autoimmune Encephalitis
ABSTRACT Background Autoimmune encephalitis (AE) in children represents a group of immune‐mediated brain disorders with mild to severe neurological complications that are mostly recoverable with appropriate timely therapy. AE is complicated to diagnose and manage, particularly in Latin America, where access to diagnostic tests and treatments is limited. This study aimed to compare clinical outcomes in pediatric patients with AE who tested positive for autoantibodies versus those who tested negative. Methods We conducted a retrospective cohort, secondary analysis of the multicenter study REAL LABIC, including data from multiple countries in Latin America. We divided patients with AE into two groups based on their autoimmune antibody status: those with positive antibodies (Ab+) and those with negative antibodies (Ab−). We compared presentation, treatment responses, and clinical outcomes between the two groups. Results A total of 37 (59.7%) were Ab+, while 25 (40.3%) were Ab−. Neurological symptoms at admission were similar between groups, except for behavioral disturbances, which were more frequent in Ab+ patients (89% vs. 60%, p = 0.012) and required more aggressive treatment, including second‐line therapies, intensive care unit (ICU) admission, and mechanical ventilation. Conclusions Children with antibody‐positive AE in Latin America had a more severe disease course and required more intensive therapeutic interventions than antibody‐negative patients. These findings underscore the importance of timely diagnosis and equitable access to advanced diagnostic and therapeutic resources in the region.
Authors
- Jesús Domínguez-Rojas (ORCID: https://orcid.org/0000-0001-6141-6622)
- Álvaro Coronado Muñoz (ORCID: https://orcid.org/0000-0001-5349-5260)
- Verónica María Alaña Peña (ORCID: https://orcid.org/0009-0000-4340-6754)
- Carmen Rojas Julián (ORCID: https://orcid.org/0000-0001-9930-6496)
- José Domingo Barrientos-Guerra (ORCID: https://orcid.org/0000-0002-0266-413X)
- Christoper Alexander Alarcon-Ruiz (ORCID: https://orcid.org/0000-0003-3907-2784)
- Daniel Agustín Godoy (ORCID: https://orcid.org/0000-0002-5250-6965)
- Karen Perales Caballero (ORCID: https://orcid.org/0000-0002-1794-0678)
- Maricela García-Arellano
- Ruth Vela-Sosa (ORCID: https://orcid.org/0000-0001-5346-806X)
- Cíntia Johnston (ORCID: https://orcid.org/0000-0002-1504-9160)
- Miguel A. Vences (ORCID: https://orcid.org/0000-0002-8538-6242)
- Juan David Roa (ORCID: https://orcid.org/0000-0002-9229-0740)
- Pablo Vásquez‐Hoyos (ORCID: https://orcid.org/0000-0002-4892-5032)
- Cibele Lopes Queiroz de Lima (ORCID: https://orcid.org/0009-0002-7802-4849)
- Mercedes A. Suarez‐Loro (ORCID: https://orcid.org/0000-0001-6533-988X)
Institutions
- Albert Einstein College of Medicine (US)
- Montefiore Medical Center (US)
- Universidade de São Paulo (BR)
- Universidad El Bosque (CO)
- Universidad Peruana Cayetano Heredia (PE)
- Universidad de San Martín de Porres (PE)
- Universidad Científica del Sur (PE)
- Hospital General San Juan de Dios (GT)
- Universidad Nacional de Colombia (CO)
- Instituto Nacional de Salud del Niño (PE)
- EsSALUD (PE)
- Instituto Nacional de Salud del Niño-San Borja (PE)
- Hospital Nacional Edgardo Rebagliati Martins (PE)
- Meditech Foundation (CO)
Publication Details
- Journal
- Annals of the Child Neurology Society
- Published
- 2026-11-15
- DOI
- https://doi.org/10.1002/cns3.70097
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00